UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Gender differences in cannabis use disorder symptoms: A network analysis

Drug and alcohol dependence, 2023-02, Vol.243, p.109733, Article 109733

2023

Link zum Volltext

Verfügbarkeit prüfen

Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004–2019

Drug and alcohol dependence, 2024-04, Vol.257, p.111113-111113, Article 111113

2024

Link zum Volltext

Verfügbarkeit prüfen

Use of marijuana exclusively for medical purposes

Drug and alcohol dependence, 2019-02, Vol.195, p.13-15

2019

Link zum Volltext

Verfügbarkeit prüfen

Alleviation of Opioid Withdrawal by Cannabis and Delta-9-Tetrahydrocannabinol: A Systematic Review of Observational and Experimental Human Studies

Drug and alcohol dependence, 2022-12, Vol.241, p.109702-109702, Article 109702

2022

Link zum Volltext

Verfügbarkeit prüfen

Quetiapine treatment for cannabis use disorder

Drug and alcohol dependence, 2021-01, Vol.218, p.108366-108366, Article 108366

2021

Link zum Volltext

Verfügbarkeit prüfen

The influence of parent and peer disapproval on youth marijuana use mediated by youth risk perception: Focusing on the state comparison

Drug and alcohol dependence, 2022-11, Vol.240, p.109641, Article 109641

2022

Link zum Volltext

Verfügbarkeit prüfen

Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial

Drug and alcohol dependence, 2022-05, Vol.234, p.109388-109388, Article 109388

2022

Link zum Volltext

Verfügbarkeit prüfen

Young adult opioid misuse indicates a general tendency toward substance use and is strongly predicted by general substance use risk

Drug and alcohol dependence, 2022-06, Vol.235, p.109442-109442, Article 109442

2022

Link zum Volltext

Verfügbarkeit prüfen

Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms

Drug and alcohol dependence, 2007-01, Vol.86 (1), p.22-29

2007

Link zum Volltext

Verfügbarkeit prüfen

College student use of Salvia divinorum

Drug and alcohol dependence, 2008-04, Vol.94 (1), p.263-266

2008

Link zum Volltext

Verfügbarkeit prüfen

Ecstasy (MDMA) dependence

Drug and alcohol dependence, 1999-01, Vol.53 (2), p.121-124

Jansen, Karl L.R.

1999

Link zum Volltext

Verfügbarkeit prüfen

National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022

Drug and alcohol dependence, 2024-05, Vol.258, p.111086-111086, Article 111086

2024

Link zum Volltext

Verfügbarkeit prüfen

The effects of (2R,6R)-hydroxynorketamine on oxycodone withdrawal and reinstatement

Drug and alcohol dependence, 2023-12, Vol.253, p.110987-110987, Article 110987

2023

Link zum Volltext

Verfügbarkeit prüfen

Associations between cannabis use, opioid misuse and severe psychological distress in adolescents: A cross-sectional school-based study

Drug and alcohol dependence, 2024-02, Vol.255, p.111085-111085, Article 111085

2024

Link zum Volltext

Verfügbarkeit prüfen

Mental health treatment use among cannabis users aged 50+: Associations with cannabis use characteristics

Drug and alcohol dependence, 2021-06, Vol.223, p.108705-108705, Article 108705

2021

Link zum Volltext

Verfügbarkeit prüfen

Behavioral economic analysis of drug preference using multiple choice procedure data

Drug and alcohol dependence, 2008-01, Vol.93 (1), p.103-110

Greenwald, Mark K

2008

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia

Drug and alcohol dependence, 2006-07, Vol.83 (3), p.210-217

2006

Link zum Volltext

Verfügbarkeit prüfen

Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC

Drug and alcohol dependence, 2012-11, Vol.126 (1-2), p.216

2012

Link zum Volltext

Verfügbarkeit prüfen

Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]

Drug and alcohol dependence, 2006-02, Vol.81 (2), p.117

2006

Link zum Volltext

Verfügbarkeit prüfen

Use, indications and distribution in different countries of the stimulant and hallucinogenic amphetamine derivatives under consideration by WHO

Drug and alcohol dependence, 1986-06, Vol.17 (2), p.169-192

Keup, Wolfram

1986

Link zum Volltext

Verfügbarkeit prüfen

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieDrug And Alcohol Dependence

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Humans
(20)
Life Sciences & Biomedicine
(18)
Psychiatry
(18)
Science & Technology
(18)
Substance Abuse
(18)
Male
(12)
Cannabis
(11)
Hallucinogens - Therapeutic Use
(11)
Female
(10)
Adult
(9)
Marijuana
(9)
Drug Addiction
(8)
Hallucinogens
(7)
Biological And Medical Sciences
(6)
Drug Abuse
(6)
Medical Sciences
(6)
Toxicology
(6)
Addictive Behaviors
(5)
Adult And Adolescent Clinical Studies
(5)
Medical Marijuana - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(20)
MEDLINE
(20)
Ingenta
(20)
Elsevier ScienceDirect Journals Complete
(20)
Applied Social Sciences Index & Abstracts (ASSIA)
(12)
IngentaConnect Journals
(3)
PAIS Index
(1)
Sociological Abstracts
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gender differences in cannabis use disorder symptoms: A network analysis

Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004–2019

Use of marijuana exclusively for medical purposes

Alleviation of Opioid Withdrawal by Cannabis and Delta-9-Tetrahydrocannabinol: A Systematic Review of Observational and Experimental Human Studies

Quetiapine treatment for cannabis use disorder

The influence of parent and peer disapproval on youth marijuana use mediated by youth risk perception: Focusing on the state comparison

Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial

Young adult opioid misuse indicates a general tendency toward substance use and is strongly predicted by general substance use risk

Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms

College student use of Salvia divinorum

Ecstasy (MDMA) dependence

National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022

The effects of (2R,6R)-hydroxynorketamine on oxycodone withdrawal and reinstatement

Associations between cannabis use, opioid misuse and severe psychological distress in adolescents: A cross-sectional school-based study

Mental health treatment use among cannabis users aged 50+: Associations with cannabis use characteristics

Behavioral economic analysis of drug preference using multiple choice procedure data

Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia

Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC

Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]

Use, indications and distribution in different countries of the stimulant and hallucinogenic amphetamine derivatives under consideration by WHO

Aktive Filter

Suchergebnisse filtern